FIBRILLARY GLOMERULONEPHRITIS

Clinical trials for FIBRILLARY GLOMERULONEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new FIBRILLARY GLOMERULONEPHRITIS trials appear

Sign up with your email to follow new studies for FIBRILLARY GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Could this drug help people with a rare kidney disease?

Disease control Recruiting now

This study tests a drug called obinutuzumab in 20 adults with fibrillary glomerulonephritis, a rare kidney disease. The goal is to see if the drug can reduce protein in the urine and improve kidney function over 12 months. Participants must have a confirmed diagnosis and meet spe…

Matched conditions: FIBRILLARY GLOMERULONEPHRITIS

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated May 26, 2026 03:27 UTC

FIBRILLARY GLOMERULONEPHRITIS

Get alerted when new FIBRILLARY GLOMERULONEPHRITIS trials appear

Could this drug help people with a rare kidney disease?